EUVIMEDEUVIMED entdecken
Open Access

The Diagnostic Potential of Extracellular Vesicles Derived From the Blood Plasma of Glioblastoma Patients

Katja Döring, Vesna Malinova, Christoph Bettag, Veit Rohde, Matthias Schulz, Kerstin Menck, Annalen Bleckmann, Claudia Binder, Judith Büntzel

In Vivo · 2024

DOI: 10.21873/invivo.13752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Katja Döring und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Neuroradiology, Medical School Hannover, Hannover, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Extracellular Vesicles, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Biomarkers for patients suffering from glioblastoma (GBM) are scarce. Extracellular vesicles (EV) are a promising candidate for a potential biomarker. Therefore, EV concentration could be a potential biomarker of tumor burden, volume, and prognosis. PATIENTS AND METHODS: Large EV (lEV) and small EV (sEV) were isolated from 36 GBM patients' blood plasma by differential centrifugation. Nanoparticle tracking was used to measure EV concentration. Quantitative analysis of tumor volume was performed by evaluating T2/FLAIR relaxation times. RESULTS: The mean size of lEV was 173.3 nm ± 18.2 nm, while sEV measured 148.3 ± 9.0 nm. Patients with higher lEV concentrations showed a trend towards longer overall survival (36.1 vs. 16.5 months, p=0.08). Regarding inflammatory markers, higher leukocyte count was positively correlated with higher sEV concentration (r2=0.3887, DF 21, p=0.0015). No significant relationship was found between lEV or sEV concentration and tumor volume. CONCLUSION: Overall EV concentration in the peripheral blood is not a predictor of tumor volume. sEV concentration is associated with a potential pro-inflammatory metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaExtracellular VesiclesBiomarkers, TumorBrain NeoplasmsHumansMaleFemaleMiddle AgedAgedPrognosisTumor BurdenAdult

Stichwörter der Autor:innen

Extracellular vesiclesbiomarkerglioblastomaliquid biopsy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Neuroradiology, Medical School Hannover, Hannover, Germany.
  • Department of Neurosurgery, University Medical Center Goettingen, Goettingen, Germany.
  • Department of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.
  • Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, Münster, Germany.
  • Department of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany; judith.buentzel@med.uni-goettingen.de.

Zitieren

APA

Döring, K., Malinova, V., Bettag, C., Rohde, V., Schulz, M., Menck, K., Bleckmann, A., Binder, C., & Büntzel, J. (2024). The Diagnostic Potential of Extracellular Vesicles Derived From the Blood Plasma of Glioblastoma Patients. In Vivo. https://doi.org/10.21873/invivo.13752

Vancouver

Döring K, Malinova V, Bettag C, Rohde V, Schulz M, Menck K, et al. The Diagnostic Potential of Extracellular Vesicles Derived From the Blood Plasma of Glioblastoma Patients. In Vivo. 2024. doi:10.21873/invivo.13752

BibTeX
@article{Dring2024,
  author = {Döring, Katja and Malinova, Vesna and Bettag, Christoph and Rohde, Veit and Schulz, Matthias and Menck, Kerstin and Bleckmann, Annalen and Binder, Claudia and Büntzel, Judith},
  title = {The Diagnostic Potential of Extracellular Vesicles Derived From the Blood Plasma of Glioblastoma Patients},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13752}
}
Kostenlos starten →